NIH-funded research Sbir 2 grant

A new catheter designed to improve complex heart procedures

Official title: Catheter for Complex Percutaneous Coronary Intervention

Funded at Crossliner INC · NIH-11011323 · Data updated 2026-11-12

This study is testing a new type of catheter designed to help doctors place stents more easily and safely in patients with severe heart artery blockages, especially when the arteries are tricky to navigate.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionCrossliner INC
NIH-funded
Lab location1 site (Kalamazoo, United States)
Project startJuly 20, 2020
Project endJanuary 31, 2027
Funding year2025
Award (this year)$990,619
NIH project number5R44HL152835-05
Project IDNIH-11011323 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with complex coronary artery disease requiring percutaneous coronary interventions.

Less likely to help

Patients with simple coronary artery disease or those who do not require stent placement may not benefit from this research.

What this research studies

This research focuses on developing a novel guide extension catheter (GEC) to enhance the delivery of stents during complex percutaneous coronary interventions (PCIs). The new catheter aims to safely navigate challenging coronary anatomies, such as calcified lesions and tortuous vessels, which are often difficult to treat with existing devices. By incorporating a microcatheter leading tip and a pre-dilatation balloon, this approach seeks to improve the success rate of stent delivery in patients with severe coronary artery disease. The study will evaluate the effectiveness and safety of this innovative catheter in real-world clinical settings.

Why it matters

Potential benefit: If successful, this research could significantly improve treatment outcomes for patients undergoing complex heart procedures.

How similar studies have gone: Previous research has shown promise in using guide extension catheters for complex cases, but this specific approach is novel and untested.

Where this research is happening

  • Crossliner INC
    Kalamazoo, United States
    Active

Researchers

  • Principal investigator: Fischell, Tim Alexander — Crossliner INC
  • Study coordinator: Fischell, Tim Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.